tirzepatide news october 2025 SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Lilly, Novo Fight Weight Loss

Consequently, the growing obesity pipeline today comprises over 120 weight loss agents which are being developed by 60 companies across multiple mechanisms of action (MoAs) and different formulations, including many orals (see Figure 1)

A 2024 JAMA Internal Medicine trial led by Thomas Wadden found no clinically meaningful increase in depression or suicidal thoughts among semaglutide users and even a small reduction in depressive symptoms in people without prior psychopathology

While the results are promising, we dont yet have enough data to say for sure that zinc will enhance semaglutides effectiveness in the same way

A.LeMotteP

Interestingly, vagal CCK signaling is potentiated by vagal leptin signaling 266,267 , and diet-induced leptin resistance in VANs mediates impairments in vagal CCK action 268